Basel Metropolitan Area
I work with global life sciences organizations to turn AI ambition into operational reality. My focus is on enterprise AI adoption, operating models and the large-scale transformation of analytics platforms in regulated environments. With more than 15 years of experience across Roche, EY, IQVIA, BD and SAS, I operate at the intersection of life sciences, data, cloud and AI transformation. I help organizations translate complex business challenges into clear strategies, scalable platforms and operating models that create measurable business value. My experience spans global enterprise environments with complex regulatory requirements, large analytics estates and multi-stakeholder governance structures. Much of the industry conversation around AI focuses on technology. In practice, the real challenge is adoption — governance, organizational alignment, data foundations and the ability to translate AI capabilities into concrete use cases that improve decision-making and operational performance. My work therefore focuses on bridging strategy and execution: designing enterprise AI programs, building cross-functional alignment and enabling organizations to move from experimentation to scaled AI adoption. Focus areas: • Enterprise AI adoption and operating models • Cloud and analytics platform transformation • Digital and commercial transformation in life sciences • Global strategic account leadership and enterprise partnerships • Business case development, value engineering and ROI modelling • AI use case development across regulatory, clinical, medical and commercial domains
Lead the strategic global account relationship for one of the world’s largest life sciences organizations (~100,000 employees), advising on enterprise AI, cloud analytics platforms and large-scale data and AI adoption in regulated environments. I work with senior stakeholders to translate complex business challenges into scalable cloud and AI solutions across commercial, regulatory, medical and clinical domains. Key contributions: • Led the commercial shaping and advancement of a multi-year hosted managed services agreement for a SAS Viya platform hosted on AWS, enabling enterprise cloud modernization and scalable AI adoption. • Designed and prioritized AI and analytics use cases across regulatory, clinical, medical and commercial functions, including FDA documentation, protocol optimization, fraud detection and warehouse optimization. • Developed cloud and AI strategies focused on analytics modernization, Viya cloud adoption and enterprise operating models, governance and platform ownership. • Coordinated cross-functional teams across sales, consulting, product specialists and partners to align solution design, implementation scenarios and value realization. • Built business cases and ROI models to support executive decision-making and prioritization of analytics, automation and AI investments.
• Represent the Liberal Democratic Party (LDP) in the cantonal parliament of Basel-Stadt. • Shape cantonal legislation and political strategy through committee and plenary work. • Contribute to fiscal, regulatory, and social policy decisions affecting city and canton. • Initiate motions and collaborate across party lines to deliver pragmatic solutions.
• Successfully led complex multi-stakeholder negotiations for a major European agreement, collaborating with more than 30 internal stakeholders and creating an executable agreement for both organizations. • Led global account strategy for Roche, Sanofi, and Boehringer Ingelheim, driving growth across EMEA. • Negotiated pan-European distribution agreements and aligned commercial strategy across 30+ cross-functional stakeholders.
• Founded, scaled and sold a Swiss startup with 48 SKUs and national distribution partnerships. • Led brand development, legal structuring, product portfolio, and full company sale.
• Managed strategic partnerships across Roche HQ, EU5, China & Brazil, driving data & tech adoption. • Delivered multi-country growth by aligning commercial, procurement, and analytics stakeholders on long-term value.